Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series

Beyond Rheumatology 2021; 3 (2): e292
DOI: 10.4081/br.2021.65

Evaluation of aseptic technique used in interventional rheumatology: survey among Moroccan and Tunisian rheumatologists

Beyond Rheumatology 2021; 3 (2): e289
DOI: 10.4081/br.2021.54

Correlation between pain and weakness of vastus medialis evaluated by ultrasound in total knee arthroplasty

Beyond Rheumatology 2021; 3 (2): e290
DOI: 10.4081/br.2021.63

Serum calprotectin: emerging marker of rheumatoid arthritis

Beyond Rheumatology 2021; 3 (2): e294
DOI: 10.4081/br.2021.73

Sjögren syndrome diagnosis in a cohort of patients with breast cancer: a single-center experience

Beyond Rheumatology 2021; 3 (2): e293
DOI: 10.4081/br.2021.67

An unusual dyspnea in an 87-year old woman affected by Sjögren’s syndrome

Beyond Rheumatology 2021; 3 (2): e291
DOI: 10.4081/br.2021.64

RS3PE and the role of ultrasound. A case report and brief review of the literature

Beyond Rheumatology 2021; 3 (1): e288
DOI: 10.4081/br.2021.61

On- and off-label use of rituximab in rheumatic diseases

Beyond Rheumatology 2021; 3 (1): e287
DOI: 10.4081/br.2021.56

The management of large vessel vasculitides

Beyond Rheumatology 2021; 3 (1): e286
DOI: 10.4081/br.2021.51

Recurrent ascites in systemic lupus erythematosus treated with rituximab – a case report and review of pseudo-pseudo Meigs’ syndrome

Beyond Rheumatology 2021; 3 (1): e285
DOI: 10.4081/br.2021.47

• Newer
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• Older